GENE ONLINE|News &
Opinion
Blog

2025-11-05|

Synthetic α-Synuclein Fibrils Successfully Induce Multiple System Atrophy-Like Pathology in Mice

by GOAI
Share To

Researchers have successfully demonstrated that synthetic α-synuclein fibrils can replicate in mice and induce pathology resembling multiple system atrophy (MSA). The study focused on the strain known as 1B and its propagated form, 1B^P, which were shown to trigger neurodegenerative changes similar to those observed in human MSA. This advancement addresses previous challenges related to the purification yields of fibrillar seeds, enabling more precise experimental modeling of the disease.

The findings highlight a refined experimental approach that allowed scientists to overcome technical barriers in producing sufficient quantities of synthetic α-synuclein fibrils for testing. By introducing these fibrils into mice, researchers observed pathological features consistent with MSA, including widespread accumulation of α-synuclein aggregates. These results provide new insights into the mechanisms underlying MSA and offer a potential avenue for further investigation into therapeutic strategies targeting α-synuclein-related diseases.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 5, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Actavis Pharma Updates Ciclopirox Shampoo Prescribing Information as of September 10, 2026
2026-09-10
Scroll to Top